Trend/MAs: Bullish alignment (SMA_5 > SMA_20 > SMA_200) supports an ongoing uptrend/bid under the stock.
Momentum: MACD histogram is negative (-0.0542) but contracting (bearish momentum fading), consistent with a pause/pullback within an uptrend.
RSI(6)=63.86: Mildly elevated but not overbought; room to run, but not a deep “buy-low” entry.
Key levels: Pivot 7.237 (near-term line in the sand). Resistance at 7.648 then 7.902; supports at 6.827 then 6.573.
Pattern-based forward view (provided): modest upside skew next day/week, but slightly negative 1-month expectation (-1.48%), arguing against aggressive immediate buying.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open Interest Put/Call=0.25 is call-heavy (bullish sentiment/positioning).
Flow: Put volume is 0 and call volume is 80; volume is elevated vs 30-day average (today vs avg ~22.79), suggesting attention is rising.
Open interest/participation: Today’s open interest (5315) is very high vs its 30-day average (~171%), implying added positioning recently.
Volatility: IV30 ~144.78% (very high in absolute terms), but IV percentile ~18 and IV rank ~13 suggest IV is low relative to its own recent history; premium may be relatively cheaper than usual for this name.
Net: Options lean bullish, but the signal is more “speculative interest” than a confirmed directional break.
Technical Summary
Sell
3
Buy
7
Positive Catalysts
Technical structure remains bullish via moving averages; a clean break above ~7.65 could invite momentum buying.
Options skew (low put/call) and increased activity suggest traders are leaning risk-on in the near term.
Operating loss metrics are improving YoY (narrowing losses can help sentiment even pre-revenue).
Neutral/Negative Catalysts
keeps the stock highly sentiment/liquidity-driven.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: 0 (no YoY growth; still pre-commercial in reported numbers).
Net income: -11.686M, improved ~68.78% YoY (loss narrowing).
EPS: -0.14, improved ~40% YoY.
Gross margin: 0 (consistent with no revenue; margins not yet informative).
Takeaway: Fundamentals show improving losses, but the story remains early-stage and catalyst-dependent.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so recent trend in ratings/targets cannot be confirmed.
Wall Street-style pro view (inference from profile): improving loss trajectory can support the long-term narrative.
Wall Street-style con view (inference from profile): pre-revenue status and lack of near-term catalysts make timing difficult and price action more speculative.
Influential/political trading: No recent congress trading data available; hedge fund and insider trends reported as Neutral.
Wall Street analysts forecast DRTS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRTS is 7 USD with a low forecast of 5 USD and a high forecast of 9 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast DRTS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRTS is 7 USD with a low forecast of 5 USD and a high forecast of 9 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
